[PubMed] [Google Scholar] 25.Deshmukh US, Joglekar CV, Lubree HG, Ramdas LV, Bhat DS, Naik SS, Hardikar PS, Raut DA, Konde TB, Wills AK, et al
Bi-weekly dosing of ARB-1467 LNP siRNA in HBeAg negative, virally suppressed patients with chronic HBV infection leads to deeper declines in HBsAg and potential association with IL28b [abstract]
Clinical trials show moderate-to-large effects (e.g., 25-35% wrinkle/scar improvements), though limited by sample sizes and short durations
To learn more about this antiinflammatory peptide, check out our product page on gut support peptide

PRODUCT SPECIFICATIONS: Format: 10 lyophilized vials (consistent lot number for study continuity) Strength: 100mg per vial Storage: -20C, protected from light Reconstitution: Bacteriostatic water (not included) COA: Available for each production batch Intended Use: Research Use Only NOT for human consumption RESEARCH APPLICATIONS: Collagen synthesis pathway studies Tissue regeneration research Anti-inflammatory cascade investigation Wound healing modulation studies Antioxidant mechanism research INSTITUTIONAL VALUE PROPOSITION: Consistent lot number across 10 vials ensures experimental reproducibility Cost-effective bulk pricing for labs running extended study protocols Same-day shipping for time-sensitive research timelines Net-30 payment terms available for qualifying institutions QUALITY ASSURANCE: Synthesized in FDA-registered facilities under cGMP protocols Third-party COA verification (purity, endotoxin levels) Full chain-of-custody documentation for audit compliance REGULATORY NOTICE: This product is manufactured and distributed for research purposes only
